Press Releases

Three Movers to Watch for: Cognizant Technology Solutions Corporation (CTSH), Cisco Systems, Inc. (CSCO), Pfizer Inc. (PFE)

earningswp9

Cognizant Technology Solutions Corporation (CTSH) grew with the stock adding 4.95% or $2.66 to close at $56.45 on light trading volume of 20.66M compared its three months average trading volume of 6.36M. The Teaneck New Jersey 07666 based company operating under the Business Software & Services industry has been trending up for the last 52 weeks, with the shares price now 7.87% up for the period and up by 0.75% so far this year. With price target of $63.81 and a 24.23% rebound from 52-week low, Cognizant Technology Solutions Corporation has plenty of upside potential, making it a hold with a view buy.

Cognizant Technology Solutions Corporation provides information technology (IT), consulting, and business process services worldwide. The company operates through four segments: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. Its consulting and technology services include IT strategy consulting, program management consulting, operations improvement consulting, strategy consulting, and business consulting services; and application design and development, systems integration, enterprise resource planning, and customer relationship management implementation services. The company also offers enterprise information management services, such as strategic, advisory, and management consulting; enterprise data management; descriptive analytics/business intelligence; strategic corporate performance management; and packaged analytics services, as well as big data services that assist clients in managing and deriving actionable insights. In addition, it provides application testing services; and develops, licenses, implements, and supports proprietary and third-party software products, as well as offers digital technologies services. Further, the company offers outsourcing services, such as application maintenance services; IT infrastructure services; and business process services, including clinical data management, pharmacovigilance, equity research support, commercial operations, and order management. It serves various industries, including banking and insurance; healthcare and life sciences; manufacturing and logistics; retail, travel, and hospitality; consumer goods; communications; information, media, and entertainment; and technology. The company markets and sells services through its professional staff, senior management, and direct sales personnel. Cognizant Technology Solutions Corporation was founded in 1998 and is headquartered in Teaneck, New Jersey.

Cisco Systems, Inc. (CSCO) dropped $-0.18 to close the day at a new closing price of $31.27, a -0.57% decrease in value from its previous closing price that moved the stock 44.18% above its 52 week low of $24.09. A total of 20.37M shares exchanged hands during the day compared with its three month average trading volume of 22.71M. The stock, which fluctuated between $31.25 and $31.55 during the day, currently situated -1.17% below its 52 week high. The stock is up by 3.61% in the past one month and up by 1.93% over the past three months. With a one year target estimate of $33.26 and RSI of 65.29, the stock still has upside potential, making it a hold for now.

Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol (IP) based networking and other products related to the communications and information technology industry worldwide. It provides switching products, including fixed-configuration and modular switches, and storage products that provide connectivity to end users, workstations, IP phones, wireless access points, and servers; and next-generation network routing products that interconnect public and private wireline and mobile networks for mobile, data, voice, and video applications. The company also offers service provider video infrastructure, including set-top boxes, cable/telecommunications access products, and cable modems; and video software and solutions. In addition, it provides collaboration products comprising unified communications products, conferencing products, collaboration endpoints, and business messaging products; data center products, such as blade and rack servers, modular servers, fabric interconnects, software, and server access virtualization solutions; security products, including network and data center security, advanced threat protection, Web and email security, access and policy, unified threat management, and advisory, integration, and managed services; and other products, such as emerging technologies and other networking products. Further, the company offers wireless products consisting of wireless access points; network managed services; and standalone, switch-converged, and cloud managed solutions. Additionally, it provides technical support services and advanced services. The company serves businesses of various sizes, public institutions, governments, and communications service providers. Cisco Systems, Inc. sells its products directly, as well as through channel partners, such as systems integrators, service providers, other resellers, and distributors. The company was founded in 1984 and is headquartered in San Jose, California.

Pfizer Inc. (PFE) shares were up in last trading by 0.19% to $32.14. It experienced lighter than average volume on day. The stock increased in value by almost 1.48% over the past week and fell -3% in the past month. It is currently trading 0.79% above its 50 day moving average and -2.43% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -11.57% decrease in value from its one year high of $37.39. The RSI indicator value of 59.54, lead us to believe that it is a hold for now.

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., Merck KGaA, Transgene S.A., Edelris SAS, IGNITE Immunotherapy Inc., and AbCellera Biologics Inc.; and a research and development agreement with the National Cancer Institute. The company has a partnership with The University of Pittsburgh. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

 

Previous ArticleNext Article

Leave a Reply

Your email address will not be published. Required fields are marked *